1,918 Veeva Systems Inc. $VEEV Shares Sold by Candriam S.C.A.

Posted by Stanley Muller on Nov 8th, 2026

Candriam S.C.A. cut its holdings in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 0.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 287,807 shares of the technology company’s stock after selling 1,918 shares during the quarter. Candriam S.C.A.’s holdings in Veeva Systems were worth $82,455,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently added to or reduced their stakes in VEEV. Farmers & Merchants Investments Inc. raised its stake in Veeva Systems by 181.8% during the 3rd quarter. Farmers & Merchants Investments Inc. now owns 93 shares of the technology company’s stock valued at $27,000 after acquiring an additional 60 shares during the last quarter. Burkett Financial Services LLC purchased a new position in shares of Veeva Systems in the 3rd quarter valued at approximately $27,000. Pension & Wealth Management Advisors Inc. acquired a new position in shares of Veeva Systems in the third quarter valued at approximately $38,000. Lodestone Wealth Management LLC increased its holdings in shares of Veeva Systems by 68.3% in the third quarter. Lodestone Wealth Management LLC now owns 138 shares of the technology company’s stock valued at $39,000 after purchasing an additional 56 shares during the period. Finally, Compass Financial Management LLC purchased a new stake in shares of Veeva Systems during the second quarter worth approximately $27,000. Institutional investors and hedge funds own 88.20% of the company’s stock.

Veeva Systems Trading Down 1.9%

NYSE VEEV opened at $304.23 on Friday. The business’s 50 day moving average is $289.24 and its two-hundred day moving average is $211.95. Veeva Systems Inc. has a 12-month low of $148.05 and a 12-month high of $325.99. The stock has a market capitalization of $49.26 billion, a price-to-earnings ratio of 50.04, a PEG ratio of 1.30 and a beta of 0.89.

Veeva Systems (NYSE:VEEV – Get Free Report) last issued its earnings results on Wednesday, August 26th. The technology company reported $2.35 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.23 by $0.12. The business had revenue of $927.96 million during the quarter, compared to the consensus estimate of $905.38 million. Veeva Systems had a return on equity of 14.25% and a net margin of 29.34%. The company’s revenue for the quarter was up 17.6% on a year-over-year basis. During the same period in the prior year, the business posted $1.99 EPS. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. Equities analysts forecast that Veeva Systems Inc. will post 6.70 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Veeva Systems news, insider Thomas D. Schwenger sold 36,000 shares of the firm’s stock in a transaction on Thursday, August 13th. The stock was sold at an average price of $250.23, for a total value of $9,008,280.00. Following the completion of the sale, the insider owned 19,449 shares of the company’s stock, valued at approximately $4,866,723.27. This trade represents a 64.92% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Daniel J. Rizzo sold 4,841 shares of the business’s stock in a transaction on Friday, October 2nd. The stock was sold at an average price of $276.51, for a total transaction of $1,338,584.91. Following the sale, the executive vice president owned 7,665 shares in the company, valued at $2,119,449.15. The trade was a 38.71% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 56,789 shares of company stock worth $14,913,889. Insiders own 10.60% of the company’s stock.

Trending Headlines about Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

Positive Sentiment: Royal Bank of Canada raised its price target to $365 from $325 and reiterated an “outperform” rating, implying about 20% upside from the cited $304.23 share price. Royal Bank of Canada recommendations
Positive Sentiment: Needham raised its target to $360 from $310 and maintained a “buy” rating, citing about 18% potential upside from $304.23. Needham recommendations
Positive Sentiment: Stifel lifted its price target to $340 from $300, adding to the wave of upward target revisions. Stifel raises Veeva price target
Positive Sentiment: UCB selected Veeva Vault CRM as a core platform for its commercial operations and plans to use industry-specific AI for product launches and customer engagement. The deal supports Veeva’s positioning as a specialized technology provider for life sciences companies. Veeva becomes core CRM choice for major biopharma AI rollout

Wall Street Analysts Forecast Growth

VEEV has been the subject of several recent research reports. Evercore increased their price target on Veeva Systems from $185.00 to $250.00 in a report on Thursday, October 8th. Barclays boosted their price objective on shares of Veeva Systems from $360.00 to $375.00 and gave the company an “overweight” rating in a research note on Wednesday, October 28th. Raymond James Financial boosted their price objective on shares of Veeva Systems from $225.00 to $330.00 in a research note on Thursday, August 27th. The Goldman Sachs Group upped their price objective on shares of Veeva Systems from $165.00 to $180.00 in a research report on Thursday, August 27th. Finally, JPMorgan Chase & Co. raised their target price on shares of Veeva Systems from $272.00 to $299.00 in a research note on Thursday, August 27th. Nineteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $309.08.

Check Out Our Latest Report on Veeva Systems

Veeva Systems Company Profile

(Free Report)

Veeva Systems Inc develops cloud-based software, data and consulting services for the life sciences industry. Its customers include pharmaceutical and biotechnology companies, medical device makers and contract research organizations.

The company’s products support commercial operations as well as clinical, regulatory, quality and safety activities. Its offerings include Veeva Vault applications for managing documents and business processes, customer relationship management software, and data and analytics services.

Founded in 2007 and headquartered in Pleasanton, California, Veeva serves life sciences companies in markets around the world.